首页|脓毒症相关性血小板减少症的治疗进展并文献复习

脓毒症相关性血小板减少症的治疗进展并文献复习

扫码查看
脓毒症是重症监护病房(ICU)中感染死亡的主要原因,血小板减少是其常见并发症.持续性血小板减少是危重症患者预后不良的标志.脓毒症相关性血小板减少症(SAT)涉及多种病理生理机制,在凝血和炎症反应中血小板起到了关键作用.血小板计数(PLT)不仅可以预测脓毒症患者预后,也可作为脓毒症患者的治疗靶点,提高脓毒症患者抢救成功率.现就血小板在脓毒症患者发病过程中的病理生理机制、预后、治疗等方面的作用进行文献复习.
Treatment progress and literature review of sepsis-associated thrombocytopenia
Sepsis is the main cause of infection death in intensive care unit(ICU),and thrombocytopenia is a common complication.Persistent thrombocytopenia is a marker of poor prognosis in critically ill patients.Sepsis-associated thrombocytopenia(SAT)involves a variety of pathophysiological mechanisms,and platelets play a key role in coagulation and inflammatory response.Platelet count(PLT)can not only predict the prognosis of patients with sepsis,but also be used as a therapeutic target to improve the success rate of rescue in patients with sepsis.This article will review the pathophysiological mechanism,prognosis and treatment of platelets in septic patients.

SepsisPlateletsImmunityInflammationPrognosis

王巧红、陈星星、蒋永泼

展开 >

台州恩泽医疗中心(集团)恩泽医院急诊科,浙江台州 318000

浙江省台州医院重症医学科,浙江台州 318000

脓毒症 血小板 免疫 炎症 预后

浙江省卫生健康科技计划浙江省台州市科技计划

2022KY43521ywb05

2024

中国中西医结合急救杂志
中国中西医结合学会

中国中西医结合急救杂志

CSTPCD
影响因子:1.925
ISSN:1008-9691
年,卷(期):2024.31(3)
  • 7